Analyst note · Software / QEC
Algorithmiq Software / QEC
Most-funded quantum drug discovery software company — pivoting from generic chemistry to clinical pharma partnerships.
Most-funded quantum drug discovery software company — pivoting from generic chemistry to clinical pharma partnerships.
— Ledger Desk · analyst thesis
Bull case
▲ upside$15M Series A 2023 + €10M extension; Roche, AstraZeneca research partnerships; published quantum-error-mitigation work that runs on IBM hardware. Sabrina Maniscalco (Helsinki) anchors the science. Strong position as IBM Quantum chemistry partner.
Bear case
▼ downsideQuantum chemistry advantage at scale is still 3–5 years away on real hardware; software-only companies have narrow moats once hardware vendors internalize chemistry stacks. Revenue not publicly disclosed.
A profile is a snapshot of an argument, not a verdict. The Ledger updates the score nightly; the thesis we revisit only when the facts change.
— analyst-note conventions